{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 68,
        "end": 73
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 120,
        "end": 140
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 282,
        "end": 292
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 169,
        "end": 176
      }
    },
    {
      "id": "T10",
      "obj": "Disease",
      "span": {
        "begin": 244,
        "end": 260
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "17190370_3",
  "text": "The purpose of this study was to investigate the implication of the ABCB1 C3435Tpolymorphism on the pharmacokinetics of ( R ) - lansoprazole , the major enantiomer , in CYP2C19 extensive metabolizers ( EMs ) and on gastroesophageal symptoms in renal transplant recipients receiving tacrolimus ."
}
